Journal article
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE
Abstract
BACKGROUND: We sought to evaluate the real-world effectiveness and safety of prolonged anticoagulation with rivaroxaban following a provoked venous thromboembolism.
METHODS: Using US MarketScan claims from November 2012 to March 2017, we identified adults with ≥1 primary hospitalization or emergency department diagnosis code for venous thromboembolism, a provoking (major or minor, persistent or transient) risk factor, at least 3 months of …
Authors
Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J; Baker WL
Journal
The American Journal of Medicine, Vol. 132, No. 4, pp. 498–504
Publisher
Elsevier
Publication Date
April 2019
DOI
10.1016/j.amjmed.2018.11.040
ISSN
0002-9343